By Emily Atkin ( September 12, 2013, 9:24 PM EDT) -- The Federal Trade Commission told the D.C. Circuit on Wednesday that it should force Boehringer Ingelheim Pharmaceuticals Inc. to turn over documents about a $100 million drug co-promotion deal with Barr Pharmaceuticals Inc., saying the information could indicate an unlawful pay-for-delay agreement....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.